These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36721097)

  • 41. Arterial pressure waveform analysis versus thermodilution cardiac output measurement during open abdominal aortic aneurysm repair: a prospective observational study.
    Montenij LJ; Buhre WF; de Jong SA; Harms JH; van Herwaarden JA; Kruitwagen CL; de Waal EE
    Eur J Anaesthesiol; 2015 Jan; 32(1):13-9. PubMed ID: 25303970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
    Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C
    Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.
    Narasimhan V; Tan S; Kong J; Pham T; Michael M; Ramsay R; Warrier S; Heriot A
    Colorectal Dis; 2020 Nov; 22(11):1482-1495. PubMed ID: 32027455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Re-do cytoreductive surgery for peritoneal surface malignancy: Is it worthwhile?
    Narasimhan V; Cheung F; Waters P; Peacock O; Warrier S; Lynch C; Michael M; Ramsay R; Heriot A
    Surgeon; 2020 Oct; 18(5):287-294. PubMed ID: 31848069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective analysis.
    Repullo DJ; Barbois S; Leonard D; Bohlok A; Van den Audenaeren ET; Hendlisz A; Van den Eynde M; Donckier V; Kartheuser A; Liberale G
    Eur J Surg Oncol; 2021 Jul; 47(7):1661-1667. PubMed ID: 33602530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced peritoneal surface tumors during the COVID-19 pandemic: A single-institution experience.
    Radomski SN; Florissi I; Khan H; Siddiqi A; Paneitz DC; Johnston FM; Greer JB
    J Surg Oncol; 2022 Dec; 126(8):1375-1382. PubMed ID: 36081374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis.
    Lin EK; Hsieh MC; Chen CH; Lu YJ; Wu SY
    Medicine (Baltimore); 2016 Dec; 95(52):e5522. PubMed ID: 28033247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study.
    Flood MP; Waters PS; Kelly ME; Shields C; Conneely J; Ramsay R; Michael M; Loveday B; Warrier SK; Mulsow J; Heriot AG
    Surg Oncol; 2021 Jun; 37():101553. PubMed ID: 33839444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes
    Acs M; Halmy L; Isgandarova S; Blaj S; Gerken M; Hormann B; Piso P
    Anticancer Res; 2022 Feb; 42(2):1019-1029. PubMed ID: 35093903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac output measurements during high-risk Cesarean section using electrical bioreactance or arterial waveform analysis: assessment of agreement.
    Gutierrez J; Perry H; Columb M; Bampoe S; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):232-238. PubMed ID: 30302868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for the treatment of peritoneal carcinomatosis in pediatric solid malignancies: a single institution experience.
    Bautista F; Elias D; Pasqualini C; Valteau-Couanet D; Brugières L
    J Pediatr Surg; 2014 Aug; 49(8):1276-9. PubMed ID: 25092089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
    Kusamura S; Barretta F; Yonemura Y; Sugarbaker PH; Moran BJ; Levine EA; Goere D; Baratti D; Nizri E; Morris DL; Glehen O; Sardi A; Barrios P; Quénet F; Villeneuve L; Gómez-Portilla A; de Hingh I; Ceelen W; Pelz JOW; Piso P; González-Moreno S; Van Der Speeten K; Deraco M;
    JAMA Surg; 2021 Mar; 156(3):e206363. PubMed ID: 33502455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac Output Measurements Based on the Pulse Wave Transit Time and Thoracic Impedance Exhibit Limited Agreement With Thermodilution Method During Orthotopic Liver Transplantation.
    Magliocca A; Rezoagli E; Anderson TA; Burns SM; Ichinose F; Chitilian HV
    Anesth Analg; 2018 Jan; 126(1):85-92. PubMed ID: 28598912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative non-invasive versus semi-invasive cardiac index monitoring in patients with bariatric surgery - a prospective observational study.
    Lorenzen U; Pohlmann M; Hansen J; Klose P; Gruenewald M; Renner J; Elke G
    BMC Anesthesiol; 2020 Aug; 20(1):196. PubMed ID: 32778047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery.
    Mangieri CW; Moaven O; Valenzuela CD; Erali RA; Votanopoulos KI; Shen P; Levine EA
    J Surg Oncol; 2022 Mar; 125(4):703-711. PubMed ID: 34841542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan.
    Kitai T
    Surg Today; 2021 Jul; 51(7):1085-1098. PubMed ID: 33185798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Acs M; Gerken M; Gajic I; Mayr M; Zustin J; Piso P
    Langenbecks Arch Surg; 2022 Nov; 407(7):3057-3067. PubMed ID: 35732846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies.
    Wong LCK; Wong JSM; Seo CJ; Soo KC; Ong CJ; Chia CS
    Int J Hyperthermia; 2022; 39(1):1195-1201. PubMed ID: 36096487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study.
    Di Leo A; Corvasce A; Weindelmayer J; Mason EJ; Casella F; de Manzoni G
    Updates Surg; 2020 Dec; 72(4):1207-1212. PubMed ID: 32410159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?
    Strong EA; Livingston A; Gracz M; Peltier W; Tsai S; Christians K; Gamblin TC; Kersting K; Clarke CN
    J Surg Res; 2022 Oct; 278():31-38. PubMed ID: 35588572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.